These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2852324)

  • 1. Cholecystokinin modulates neurotransmission through the dentate gyrus.
    Sinton CM
    Neurosci Lett; 1988 Dec; 95(1-3):341-6. PubMed ID: 2852324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholecystokinin and cholecystokinin antagonists enhance postsynaptic excitability in the dentate gyrus.
    Sinton CM
    Peptides; 1988; 9(5):1049-53. PubMed ID: 3244557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholecystokinin and an evoked response in the dentate gyrus.
    Sinton CM
    Neuropeptides; 1988 Jul; 12(1):29-34. PubMed ID: 3419558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of cholecystokinin and cholecystokinin antagonists on synaptic function in the CA1 region of the rat hippocampal slice.
    Jaffe DB; Aitken PG; Nadler JV
    Brain Res; 1987 Jul; 415(1):197-203. PubMed ID: 3040174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonists of central and peripheral behavioral actions of cholecystokinin octapeptide.
    Crawley JN; Stivers JA; Hommer DW; Skirboll LR; Paul SM
    J Pharmacol Exp Ther; 1986 Feb; 236(2):320-30. PubMed ID: 3003339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of synaptic transmission in the hippocampus by cholecystokinin (CCK) and its antagonism by a CCK analog (CCK27-33).
    MacVicar BA; Kerrin JP; Davison JS
    Brain Res; 1987 Mar; 406(1-2):130-5. PubMed ID: 3032354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of cholecystokinin-receptor antagonists on cholecystokinin-stimulated bile flow in dogs.
    Westfall S; Andrus C; Schlarman D; Kaminski DL
    Surgery; 1991 Mar; 109(3 Pt 1):294-300. PubMed ID: 2000561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemically administered cholecystokinin affects an evoked potential in the hippocampal dentate gyrus.
    Dahl D
    Neuropeptides; 1987; 10(2):165-73. PubMed ID: 3683771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholecystokinin-dopamine receptor interactions as studied with cholecystokinin receptor antagonists.
    Murphy RB
    Prog Clin Biol Res; 1985; 192():105-13. PubMed ID: 3001746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unsulfated CCK-8 not blocked by proglumide or CR 1409 in the mouse abdominal irritant-induced stretching assay: possible central site of action.
    Ambrose FG; Barbaz BS; Autry WL; Browne RG; Liebman JM
    Peptides; 1989; 10(1):31-4. PubMed ID: 2748423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a new proglumide analogue CR 1392 on pancreatic exocrine secretion in the rat.
    Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
    Digestion; 1989; 42(2):61-9. PubMed ID: 2475379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracerebroventricular injection of cholecystokinin octapeptide elevates plasma prolactin levels through stimulation of vasoactive intestinal polypeptide.
    Tanimoto K; Tamminga CA; Chase TN; Nilaver G
    Endocrinology; 1987 Jul; 121(1):127-32. PubMed ID: 3297634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholecystokinin and its antagonist lorglumide respectively attenuate and facilitate morphine-induced inhibition of C-fiber evoked discharges of dorsal horn nociceptive neurons.
    Kellstein DE; Price DD; Mayer DJ
    Brain Res; 1991 Feb; 540(1-2):302-6. PubMed ID: 2054623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the CCK-A receptor antagonist CR 1409 on the activity of rat midbrain dopamine neurons.
    Zhang J; Chiodo LA; Freeman AS
    Peptides; 1991; 12(2):339-43. PubMed ID: 2067986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholecystokinin octapeptide increases spontaneous glutamatergic synaptic transmission to neurons of the nucleus tractus solitarius centralis.
    Baptista V; Zheng ZL; Coleman FH; Rogers RC; Travagli RA
    J Neurophysiol; 2005 Oct; 94(4):2763-71. PubMed ID: 16093341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholecystokinin-8 sulfate modulates the anticonvulsant efficacy of vigabatrin in an experimental model of partial complex epilepsy in the rat.
    Ferraro G; Sardo P
    Epilepsia; 2009 Apr; 50(4):721-30. PubMed ID: 19220409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CR-1409: a potent inhibitor of cholecystokinin-stimulated amylase release and cholecystokinin binding in rat pancreatic acini.
    Iwamoto Y; Yamamoto R; Kuzuya T
    Pancreas; 1987; 2(1):85-90. PubMed ID: 2437574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholecystokinin-8 and proglumide modulation of electrically elicited eating.
    Schneider LH
    Prog Clin Biol Res; 1985; 192():123-30. PubMed ID: 4080705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholecystokinin [corrected] octapeptide modulates dopamine release in rat striatum.
    Rakovska A
    Neurosci Lett; 1995 Aug; 195(3):151-4. PubMed ID: 8584197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bidirectional modulation of GABAergic transmission by cholecystokinin in hippocampal dentate gyrus granule cells of juvenile rats.
    Deng PY; Lei S
    J Physiol; 2006 Apr; 572(Pt 2):425-42. PubMed ID: 16455686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.